Vaccine

Article	Citations
Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003–2024)	252
Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination	212
Corrigendum to ‘A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older’ Vac	163
Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines	159
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom	128
Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination	107
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom	105
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-con	104
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines	100
U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic	93
Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season	92
Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations	90
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study	82
Editorial Board/Aims and Scope	82
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study	81
“Every interaction you have …should be an opportunity to discuss and offer influenza vaccination”. Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families li	81
Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019	79
Collateral damage from debunking mRNA vaccine misinformation	79
Managing multiplicity in clinical vaccine studies – A case study using a gatekeeping testing strategy	78
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults	76
Erratum to “Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals” [Vaccine 41(37) (2023) 5469-5476]	75
Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971	75
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study	74
Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2	71
Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008–2019	70

The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs	70
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants	65
Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods	65
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis	65
Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial	63
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states	63
“Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study	63
Humoral immune response profile of a cattle herd vaccinated with 5- and 10-times Bakirköy strain sheep pox vaccine under field conditions	62
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents	62
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria	61
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database	59
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation	55
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort	55
Corrigendum to “Recombinant BCGΔBCG1419c protects outbred mice against M. tuberculosis challenge” [Vaccine 61 (2025) 127347]	55
Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders	54
Assessing commutability of the first WHO International Standard for antiserum to respiratory syncytial virus	54
Timeliness and completeness of serial routine vaccinations among 8062 rural children in southwest China during the COVID-19 pandemic: A multi-stage stratified cluster sampling survey in 1094 villages	53
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study	52
Nationwide rollout of HPV vaccination in Nepal: Early key insights	52
Editorial Board/Aims and Scope	51
Long-term impact of rotavirus vaccination on all-cause and rotavirus-specific gastroenteritis and strain distribution in Central Kenya: An 11-year interrupted time-series analysis	51
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine	50
Editorial Board/Aims and Scope	50
Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors	49
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts	49
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate	49
Editorial Board/Aims and Scope	49
TAK − 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice	48
Erratum to “Motivational interviewing and vaccine acceptance in children: The MOTIVE study” [Vaccine 40(12) (2022) 1846–1854]	48
Effectiveness of the varicella vaccine in the real world, a matched case-control study	47
Corrigendum to ‘Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice’ [Vaccine 39 (2021) 6213–6220]	47
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study	47
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process	47
Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus	47
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States	46
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling	45
Systematic review of pro-equity strategies to improve vaccination among priority populations	45
The impact of Facebook’s vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis	45
Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation	44
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination	44
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants	44
A scoping review of multicomponent interventions to improve uptake of routine childhood vaccines in low- and middle-income countries	43
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS coloni	43
COVID-19 and seasonal influenza: The potential 2021–22 “Twindemic”	42
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21	42
The social lives of the SARS-CoV-2 vaccines: A qualitative study of vaccine understandings and decision-making among people of Black ethnicities in London, UK	42
The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies	42
Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh	42
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2	41
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics	41

Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis	41
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus	41
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental chal	41
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink	40
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate	40
Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels	40
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children	39
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic	39
Safety monitoring of health outcomes following influenza vaccination during the 2023–2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series	39
A new method for testing avian metapneumovirus vaccine efficacy: Evaluation of tracheal ciliary activity after a challenge	39
Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA)	38
The U.S. COVID-19 vaccination program: A look back and future directions	38
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up	38
Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants	38
Characteristics of reported mumps cases in the United States: 2018–2023	38
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England	37
Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate	37
Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean	37
UK healthcare professionals’ attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration	37
Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera	37
Weaving a public health network: Process and results from an evaluation of CDC’s Prevention Research Centers Vaccine Confidence Network	37
A decade of rotavirus vaccination in the World Health Organization African Region: An in-depth analysis of vaccine coverage from 2012 to 2023	37
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the fi	36
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic	36
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010	36
A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine	36
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations	35
Analysis of HPV vaccination and influencing factors among 9–14-year-old girls in underdeveloped areas of northwestern China: A cross-sectional survey report on guardians	35
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years an	35
Assessing vaccination intentions and perceptions among pregnant women in Italy: A multicenter cross-sectional study in the context of mandatory policies and the COVID-19 pandemic	35
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea	35
IFITM3-deficient mice as a model for testing influenza virus vaccines via the intramuscular route	34
Racial and ethnic differences among Mpox vaccination recipients by vaccination facility type in New York City—August–December 2022	34
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)	34
Corrigendum to “I want to chat with a person”: a qualitative longitudinal cohort study in England exploring drivers of sub-optimal childhood vaccination uptake” [Vaccine 62 (2025) 127462]	34
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding women	34
Measles seroprevalence among individuals serologically tested in Ontario, Canada	34
Vaccine misinformation among Arabic-speakers in Australia and the audience and appetite for a game-based intervention	34
Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework	33
The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana	33
Identification of T-cell epitopes of the intracellular parasite Babesia bovis by immunopeptidomic analysis of BoLA-II presented peptides	33
Examining the independent and interactive roles of intolerance of uncertainty in vaccination intent	33
A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein	33
Healthcare professional and professional stakeholders’ perspectives on vaccine mandates in Switzerland: A mixed-methods study	32
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates	32
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysacchar	32
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys	32
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates a	32
HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis	32
Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study	32
Determinants of immunization in polio super high-risk union councils of Pakistan	32
Use of an adapted participatory learning and action cycle to increase knowledge and uptake of child vaccination in internally displaced persons camps (IVACS): A cluster-randomised controlled trial	32
Editorial Board	31
Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia	31
A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs t	31
The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina	31
Corrigendum to “Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurell	30
Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs	30
County-level correlates of completed HPV vaccination in Indiana	30
Harmonized case definitions for endpoints in vaccine efficacy trials are needed	30
Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis	30
“COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adu	30
Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6–23 months in Kenya: 2019–2021	30
Documenting human papillomavirus vaccine refusal among adolescents in electronic health records: A mixed methods study	30
Strategies to improve interprofessional communication regarding maternal and infant RSV immunization	30
Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigens	30
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster	30
How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?	30
Associations between family planning, healthcare access, and female education and vaccination among under-immunized children	30
In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine	30
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use	30
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine	30
Intent to receive flu vaccine and influenza vaccination coverage among health professionals during 2019, 2020 and 2021 campaigns in Côte d’Ivoire	30
Analysis of health claims data on vaccination coverage in older adults in Bavaria, Germany: Influenza, pneumococcus and herpes zoster	30
Corrigendum to, “Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey” [Vaccine (2024) Dec 2 42(26) 126437]	30
HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study	30
Analyzing attitudes toward COVID-19 vaccine decision making among pregnant women in Pakistan	30
Safe and efficacious inactivated immersion vaccine against KG+ phenotype of emerging bacterial pathogen Lactococcus garvieae for early developmental stage of rainbow trout (Oncorhynchus mykiss) in Ind	30
Mumps virus neurovirulence assessment-impact of viral doses, animal sex and age on results dispersion	30
Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community	30

Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province, China	29
Construction of a Lactobacillus plantarum-based claudin-3 targeting delivery system for the development of vaccines against Eimeria tenella	29
COVID-19 vaccine decision-making among Black women: A qualitative study	29
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022	29
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer	29
The relationship between state vaccination exemption policies and MMR vaccination trends in the U.S.	29
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-s	29
Consultation report – considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries	29
Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults	29
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18–24 Months: A phase Ⅳ clinical trial	29
Effective mRNA-based therapy using E7 antigen and IL-12 cytokine in head and neck cancer mice models	29
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development	29
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan	28
Editorial Board	28
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design	28
Corrigendum to “Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III tria	28
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles	28
Editorial Board/Aims and Scope	28
Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observat	28
Pertussis burden and acellular pertussis vaccine effectiveness in high risk children	28
Editorial Board/Aims and Scope	28
Editorial Board/Aims and Scope	27
Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health	27
Vaccination patterns and up-to-date status of children 19–35 months, 2011–2021	27
Need for a contingency dimension when planning vaccine development in a pandemic environment	27
Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008–2018)	27
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET	27
Crowdfunding narratives and the valuation of vaccines for COVID-19	27
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients	27
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate	27
Comparison of performance of varicella vaccines via infectious disease modeling	27
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents	27
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019–2020	27
Public health impact and cost-effectiveness of implementing a ‘pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico	27
Editorial Board/Aims and Scope	27
Determinants of COVID-19 vaccine hesitancy and resistance in Russia	27
A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent)	26
New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada	26
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study	26
Persistence of immunity in children aged 2 months and 7 months – 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine	26
“EvoVax” – A rationally designed inactivated Salmonella Typhimurium vaccine induces strong and long-lasting immune responses in pigs	26
Editorial Board/Aims and Scope	26
Pertussis in Asia: Recent country-specific data and recommendations	26
Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine	26
Evaluation of anti-Pertussis antibody levels in Iranian infants and children: Is it time to include booster acellular Pertussis Vaccines in the immunization schedule?	26
The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III	26
Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study	26
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial	26
Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection	26
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers	26
Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria	25
HPV vaccination coverage and determinants in adolescent girls with disability: a scoping review	25
Vaccine value profile for Salmonella enterica serovar Paratyphi A	25
Staff and caregivers' perceptions of digital storytelling to increase influenza vaccine confidence in an urban safety-net healthcare system	25
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study	25
Assessing effects of pneumococcal vaccination (PCV13) and rotavirus vaccination (RV) on colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in Guatemalan children	25
Single immunization of non-adjuvanted recombinant TTFC-mi3 nanoparticle vaccine elicited a rapid and potent protective immunity against tetanus	25
Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks	25
COVID-19 vaccine attitudes, beliefs, intentions and behaviors among pregnant women within the context of dynamic national policy recommendations in Brazil, Ghana, Kenya, and Pakistan	25
Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh	25
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens	25
The relationship between the immunogenicity and reactogenicity of vaccines: A narrative review	25
Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model	25
Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities	25
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection	25
Seroprotection against tetanus in the Italian general population	25
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study	25
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) S	25
Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis	25
Increasing vaccination coverage among healthcare workers: Active call and mandatory laws. Data from a large general hospital in Southern Italy	25
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets	25
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization R	24
Mucosal COVID-19 vaccines in clinical development	24
Utility of edible plant-derived exosome-like nanovesicles as a novel delivery platform for vaccine antigen delivery	24
Vaccines against Neisseria meningitidis serogroup B strains – What does genomics reveal on the Portuguese strain’s coverage	24
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vacc	24
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023	24
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan	24
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic	24
Factors associated with vaccination intention and uptake over time in a sample of older Australians	24
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study	24
Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged	24
Vaccine candidate based on a baculovirus expressed VP2 provides full protection from epizootic hemorrhagic disease virus serotype 8 in calves	24
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses’ attitudes towards designing and delivering a HPV educational intervention in post-primary schools for	24
Efficiency of indirect protection of COVID-19 vaccination and interactions between indirect and direct protection on household transmission	23
Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019	23
Post-vaccination fever in infants: Real-world data analysis using a childcare mobile application	23
Enhancing NA immunogenicity through novel VLP designs.	23
Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain	23
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in Australia	23
Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo	23
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers	23
An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis	23
Comparison of SARS-CoV-2 antibody responses following the second dose of BNT162b2 and mRNA-1273 vaccines in people living with HIV-1	23
Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study	23